Highlight
The study found no statistically significant difference in overall survival (OS), disease-specific survival (DSS), or recurrence-free survival (RFS) between patients undergoing thyroid lobectomy (TL) and those undergoing total thyroidectomy (TT) plus radioactive iodine (RAI) for lateral neck metastases (N1b).
Thyroid lobectomy may be a safe and effective treatment option for a carefully selected cohort of N1b PTC patients, potentially sparing them from the lifelong complications associated with total thyroidectomy and adjuvant RAI.
Specialty calculators
For clinical reference; use professional judgment.
